指南与共识重症综合管理与镇静镇痛消化、代谢与肾脏急症

儿童血液与肿瘤疾病重症患儿红细胞输注支持建议:儿童重症输血与贫血专家倡议

Recommendations on RBC Transfusion Support in Children With Hematologic and Oncologic Diagnoses From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.
指南 / 共识 · Pediatr Crit Care Med · 2018-01-01
一句话结论儿童重症输血与贫血专家倡议推荐:镰状细胞病患儿全麻手术前输血目标血红蛋白10 g/dL而非低于30%,病情恶化时选交换输血而非单纯输血;肿瘤或造血干细胞移植患儿血红蛋白7-8 g/dL。

儿童重症输血与贫血专家倡议(Transfusion and Anemia Expertise Initiative)由38名国际多学科专家组成,其中血液/肿瘤亚组7人,通过PubMed、EMBASE和Cochrane Library检索1980年至2017年5月的文献,采用Research and Development/UCLA Appropriateness Method达成一致性,并用GRADE方法总结证据。血液/肿瘤亚组共制定14条建议(7条临床、7条研究),所有建议一致性均超过80%。对镰状细胞病患儿,推荐全麻手术前输血目标血红蛋白10 g/dL而非血红蛋白低于30%,病情恶化时选交换输血而非单纯输血;对肿瘤疾病或造血干细胞移植患儿,推荐血红蛋白7-8 g/dL。小手术前、急性卒中或肺动脉高压的镰状细胞病患儿因证据不足未能给出输血阈值建议。

要点

  • 镰状细胞病患儿需全麻手术前,推荐输血目标血红蛋白10 g/dL而非血红蛋白低于30%(专家倡议推荐)。
  • 镰状细胞病患儿病情恶化(基于临床判断)时,推荐交换输血而非单纯(非交换)输血;否则推荐单纯非交换红细胞输注。
  • 肿瘤疾病或造血干细胞移植患儿,推荐血红蛋白浓度7-8 g/dL作为输血阈值。
  • 镰状细胞病患儿行小手术前、急性卒中或合并肺动脉高压时,证据不足,未能给出输血阈值建议。
  • 血液/肿瘤亚组共制定14条建议(7条临床、7条研究),所有建议一致性均超过80%。

适用人群与场景

  • 重症儿童,具体为血液/肿瘤疾病患儿,包括镰状细胞病、肿瘤疾病或接受造血干细胞移植者。
  • 场景为儿童重症监护,涉及全麻手术前、小手术前、急性卒中、肺动脉高压及病情恶化等阶段。

诊断标准与关键阈值

  • 镰状细胞病患儿全麻手术前输血目标:血红蛋白浓度10 g/dL,而非血红蛋白低于30%。
  • 肿瘤疾病或造血干细胞移植患儿输血阈值:血红蛋白浓度7-8 g/dL。

处置流程与药物剂量

  • 镰状细胞病患儿需全麻手术前,推荐红细胞输注以达到目标血红蛋白浓度10 g/dL,而非血红蛋白低于30%。
  • 镰状细胞病患儿病情恶化(基于临床判断)时,推荐交换输血而非单纯(非交换)输血;否则推荐单纯非交换红细胞输注。
  • 肿瘤疾病或接受造血干细胞移植患儿,推荐血红蛋白浓度7-8 g/dL作为输血阈值。

红旗征与不能漏的情况

  • 镰状细胞病患儿病情恶化(基于临床判断)时,推荐交换输血而非单纯输血。

研究设计与关键结果

  • 儿童重症输血与贫血专家倡议血液/肿瘤亚组由7名专家组成,共制定14条建议(7条临床、7条研究),所有建议一致性均超过80%。
  • 镰状细胞病患儿全麻手术前,推荐红细胞输注目标血红蛋白10 g/dL而非血红蛋白低于30%;病情恶化时推荐交换输血而非单纯输血,否则推荐单纯非交换红细胞输注。
  • 肿瘤疾病或造血干细胞移植患儿,推荐血红蛋白7-8 g/dL。
  • 镰状细胞病患儿行小手术前、急性卒中或肺动脉高压时,证据不足,未能给出输血阈值建议。
  • 因证据缺乏,需要研究明确这些患者的适当输血阈值。

证据类型、等级与局限

  • 证据类型:国际多学科专家共识会议(38名专家,血液/肿瘤亚组7名),采用Research and Development/UCLA Appropriateness Method达成一致性,并用GRADE方法总结证据。
  • 证据等级:推荐基于证据,证据缺乏时为专家意见;所有建议一致性均超过80%。
  • 局限:小手术前、急性卒中或肺动脉高压的镰状细胞病患儿输血阈值证据不足;肿瘤疾病或造血干细胞移植患儿输血阈值证据缺乏,需要研究明确。

对床旁实践的改变

  • 对镰状细胞病患儿全麻手术前,输血目标为血红蛋白10 g/dL而非血红蛋白低于30%,改变以往以血红蛋白低于30%为目标的实践。
  • 镰状细胞病患儿病情恶化时,选择交换输血而非单纯输血;否则选择单纯非交换红细胞输注。
  • 对肿瘤疾病或造血干细胞移植重症患儿,采用血红蛋白7-8 g/dL作为输血阈值。
  • 对镰状细胞病患儿行小手术前、急性卒中或肺动脉高压时,因证据不足,无法给出明确输血阈值建议。

指南或共识出处

  • Pediatric Critical Care Transfusion and Anemia Expertise Initiative Recommendations on RBC Transfusion Support in Children With Hematologic and Oncologic Diagnoses(儿童重症输血与贫血专家倡议),发表于Pediatr Crit Care Med。

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To present the recommendations and supporting evidence for RBC transfusions in critically ill children with hematologic and oncologic disease from the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

DESIGN: Consensus conference series of international, multidisciplinary experts in RBC transfusion management of critically ill children.

METHODS: The panel of 38 experts developed evidence-based and, when evidence was lacking, expert-based clinical recommendations and research priorities for RBC transfusions in critically ill children. The hematologic/oncologic subgroup included seven experts. Electronic searches were conducted using PubMed, EMBASE, and Cochrane Library databases from 1980 to May 2017. Agreement was obtained using the Research and Development/UCLA Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method.

RESULTS: The hematologic/oncologic subgroup developed 14 recommendations (seven clinical, seven research); all achieved greater than 80% agreement. In patients with sickle cell disease, Transfusion and Anemia Expertise Initiative recommends: 1) RBC transfusion to achieve a target hemoglobin concentration of 10 g/dL rather than hemoglobin of less than 30% prior to surgical procedures requiring general anesthesia and 2) exchange transfusion over simple (nonexchange) transfusion if the child's condition is deteriorating (based on clinical judgment), otherwise a simple, nonexchange RBC transfusion is recommended. There is insufficient evidence to make recommendations on transfusion thresholds for patients with sickle cell disease prior to minor procedures, with acute stroke or with pulmonary hypertension. For patients with oncologic disease or undergoing hematopoietic stem cell transplant, a hemoglobin concentration of 7-8 g/dL is recommended. Due to lack of evidence, research is needed to clarify the appropriate transfusion thresholds in these patients.

CONCLUSIONS: Transfusion and Anemia Expertise Initiative developed specific pediatric recommendations regarding RBC transfusion management in critically ill children with sickle cell disease, oncologic disease, and hematopoietic stem cell transplant and recommendations to help guide future research priorities.

来源:Pediatr Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Steiner ME, Zantek ND, Stanworth SJ, et al. Recommendations on RBC Transfusion Support in Children With Hematologic and Oncologic Diagnoses From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med. 2018. PMID: 30161070. doi:10.1097/PCC.0000000000001610

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。